Johnson & Johnson (NYSE: JNJ) has announced the acquisition of Shockwave Medical, Inc. (Nasdaq: SWAV) for a staggering $335.00 per share in cash, totaling an enterprise value of approximately $13.1 billion, inclusive of cash acquired. This definitive agreement, approved by both companies’ boards of directors, marks a significant expansion of Johnson & Johnson MedTech’s footprint…